Zyversa Therapeutics Stock Price Prediction
| ZVSA Stock | 1.12 0.10 8.20% |
Momentum 43
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (1.80) | Wall Street Target Price 20 | EPS Estimate Current Quarter (1.60) |
Using ZyVersa Therapeutics hype-based prediction, you can estimate the value of ZyVersa Therapeutics from the perspective of ZyVersa Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ZyVersa Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying ZyVersa because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ZyVersa Therapeutics after-hype prediction price | USD 1.12 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ZyVersa |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ZyVersa Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ZyVersa Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of ZyVersa Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ZyVersa Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ZyVersa Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ZyVersa Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting ZyVersa Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ZyVersa Therapeutics' historical news coverage. ZyVersa Therapeutics' after-hype downside and upside margins for the prediction period are 0.06 and 7.16, respectively. We have considered ZyVersa Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ZyVersa Therapeutics is unstable at this time. Analysis and calculation of next after-hype price of ZyVersa Therapeutics is based on 3 months time horizon.
ZyVersa Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ZyVersa Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ZyVersa Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ZyVersa Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 5.99 | 0.01 | 0.00 | 1 Events / Month | 3 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.12 | 1.12 | 1.82 |
|
ZyVersa Therapeutics Hype Timeline
ZyVersa Therapeutics is at this time traded for 1.12. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.0. ZyVersa is projected to increase in value after the next headline, with the price projected to jump to 1.12 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 1.82%, whereas the daily expected return is at this time at 0.21%. The volatility of related hype on ZyVersa Therapeutics is about 25671.43%, with the expected price after the next announcement by competition of 1.12. Net Loss for the year was (98.3 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next projected press release will be very soon. Check out ZyVersa Therapeutics Basic Forecasting Models to cross-verify your projections.ZyVersa Therapeutics Related Hype Analysis
Having access to credible news sources related to ZyVersa Therapeutics' direct competition is more important than ever and may enhance your ability to predict ZyVersa Therapeutics' future price movements. Getting to know how ZyVersa Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ZyVersa Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CNSP | Cns Pharmaceuticals | (0.15) | 4 per month | 0.00 | (0.07) | 10.42 | (10.71) | 70.89 | |
| EFTR | Effector Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VECT | VectivBio Holding AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AVRO | AVRO Old | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMMX | Immix Biopharma | 0.02 | 10 per month | 4.47 | 0.05 | 9.09 | (7.69) | 33.17 | |
| HEPA | Hepion Pharmaceuticals | 0.01 | 5 per month | 0.00 | (0.10) | 17.65 | (11.11) | 86.86 | |
| VIRI | VIRI Old | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ZURA | Zura Bio Limited | (0.09) | 5 per month | 0.00 | (0.22) | 9.21 | (9.96) | 25.04 | |
| NAVB | Navidea Biopharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ZyVersa Therapeutics Additional Predictive Modules
Most predictive techniques to examine ZyVersa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ZyVersa using various technical indicators. When you analyze ZyVersa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ZyVersa Therapeutics Predictive Indicators
The successful prediction of ZyVersa Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ZyVersa Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ZyVersa Therapeutics based on analysis of ZyVersa Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ZyVersa Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ZyVersa Therapeutics's related companies.
Story Coverage note for ZyVersa Therapeutics
The number of cover stories for ZyVersa Therapeutics depends on current market conditions and ZyVersa Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ZyVersa Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ZyVersa Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ZyVersa Therapeutics Short Properties
ZyVersa Therapeutics' future price predictability will typically decrease when ZyVersa Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ZyVersa Therapeutics often depends not only on the future outlook of the potential ZyVersa Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ZyVersa Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 97.5 K | |
| Cash And Short Term Investments | 3.1 M |
Complementary Tools for ZyVersa Stock analysis
When running ZyVersa Therapeutics' price analysis, check to measure ZyVersa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZyVersa Therapeutics is operating at the current time. Most of ZyVersa Therapeutics' value examination focuses on studying past and present price action to predict the probability of ZyVersa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZyVersa Therapeutics' price. Additionally, you may evaluate how the addition of ZyVersa Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |